Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: A Gynecologic Oncology Group study

Published 2011 View Full Article

Authors

Keywords

Journal

GYNECOLOGIC ONCOLOGY

Volume 123, Issue 1, Pages 19-26

Publisher

Elsevier BV

Online

2011-07-13

DOI

10.1016/j.ygyno.2011.06.022

Ask authors/readers for more resources

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

GYNECOLOGIC ONCOLOGY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Become a Peeref-certified reviewer

Ask a Question. Answer a Question.